Objetivo
BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and generalizable guidelines and techniques to enhance immunosafety of novel vaccines from pre-development to post-marketing surveillance. A compact interlocking structure provides efficient and cost-effective goal delivery, while offering the full spectrum of functionality and capacity to match the needs for predictive biomarkers and models of inflammation/autoimmunity and clinical events classification. A Technology Core has transcriptomics, genotyping, proteomics, metabolomics and data mining, with depth and capacity to discover, validate and distribute novel biomarkers. A Models Core has a full range of ex vivo/in vivo murine, small animal and non-human primate models of inflammation and biomarker discovery, with advanced immunology and imaging. A Clinical Core has capability to safely and efficiently distribute clinical studies of vaccine immunosafety from small intensive trials to large-scale studies of adult, paediatric and other populations. A Populations Core has population-scale biobank discovery, clinical cohorts (with globalisation capability, autoimmune, chronic, inflammatory and infectious disease groups), large-scale genotyping and sequencing, and a safely accessible central database for online analyses of large datasets. A Regulatory Core with expertise to synthesise outputs to generate and disseminate classifications, guidelines, reference standards for vaccine development, and inform EFPIA activities. A Management Core with track record of successful public-private projects ensures Cores interoperate to maximise discovery - validation - application - re-discovery cycles, to deliver project goals on time, within budget, while maximising interactions with other actors (EFPIA, FDA, EMA).
Ámbito científico
- natural sciencesbiological scienceszoologymammalogyprimatology
- medical and health scienceshealth sciencesinfectious diseases
- natural sciencescomputer and information sciencesdata sciencedata mining
- medical and health sciencesbasic medicineimmunology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
Convocatoria de propuestas
IMI-JU-03-2010
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
53100 SIENA
Italia
Ver en el mapa
Participantes (21)
GU2 7XH Guildford
Ver en el mapa
80539 Munchen
Ver en el mapa
La participación finalizó
L35QA LIVERPOOL 3
Ver en el mapa
75015 PARIS 15
Ver en el mapa
SW7 2AZ LONDON
Ver en el mapa
53100 Siena
Ver en el mapa
76705 Rehovot
Ver en el mapa
412 96 GOTEBORG
Ver en el mapa
La participación finalizó
SW1W 9SZ London
Ver en el mapa
3584 CS Utrecht
Ver en el mapa
La participación finalizó
10117 Berlin
Ver en el mapa
9000 Gent
Ver en el mapa
405 30 Goeteborg
Ver en el mapa
La participación finalizó
101 Reykjavik
Ver en el mapa
2300 Kobenhavn S
Ver en el mapa
1330 Rixensart
Ver en el mapa
69007 Lyon
Ver en el mapa
1060 Bruxelles / Brussel
Ver en el mapa
53100 Siena Si
Ver en el mapa
LS2 7UE Leeds
Ver en el mapa
SW17 0RE London
Ver en el mapa